🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsBuyer BewareReporting scam vendors — how to file complaints with FDA, FTC, IC3

Reporting scam vendors — how to file complaints with FDA, FTC, IC3

FDA_TrackerJim Mon, May 25, 2026 at 10:55 AM 11 replies 382 viewsPage 1 of 3
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
May 25, 2026 at 10:55 AM#1

A reference post rather than a discussion. Corrections are the point; I would rather this be right than mine. It is about vendor vetting, and it is deliberately narrow — everything I am not confident about is marked as such.

What is actually established

The pattern that distinguishes a bad batch from an exit is behaviour rather than product. A bad batch comes with communication, a reshipment offer and a batch number. An exit comes with slower replies, pressure toward less reversible payment methods, sudden discounting, and the same reassurance repeated without any new information. The product tells you less than the correspondence does.

The condition it depends on

A caveat about community reputation: it is a lagging indicator. Reports arrive weeks after orders, so a supplier can look excellent for a month after quality has already changed.

The practical version

Red flags, in rough order of how much they should worry you: no verifiable address, no batch numbers, prices far under market, vendor-commissioned tests only, pressure toward irreversible payment, and shipping with no temperature control.

What I am not sure about

What I am after is how people are distinguishing a supplier having a bad batch from a supplier on the way out. I would rather have one careful answer than five confident ones.

— FDA_TrackerJim · corrections welcome and will be edited into this post with credit
49 19Dr.Martinez, mike_mod, SarahChen_PharmD and 46 others
Reply Quote Save Share Report
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
May 25, 2026 at 11:01 AM#2
FDA_TrackerJim said:
The pattern that distinguishes a bad batch from an exit is behaviour rather than product.

Agreeing with FDA_TrackerJim, and the qualification matters more than the agreement. The useful checklist is about verifiability rather than presentation. Independent test results commissioned by buyers rather than by the seller, consistency across multiple batches over time rather than one flattering report, a physical address and a company registration that resolve, batch and lot numbers on the actual labelling, and a shipping practice that matches what the material needs. Everything a good-looking website provides is cheap to fake; none of the items above are.

48 18tyler_CSCS, VanRx_Mike, steve_okc and 45 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
May 25, 2026 at 11:07 AM#3
FDA_TrackerJim said:
The pattern that distinguishes a bad batch from an exit is behaviour rather than product.

I disagree that testing history is decisive. It tells you what a supplier did when they were being watched. Continuity of behaviour under stress — a late shipment, a failed test, a complaint — is more predictive than any run of good results.

Happy to go further on any of that.

Last edited: May 25, 2026 at 12:07 PM
47 17LondonLisa, mike_nyc, VendorMark and 44 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
Dr.KarenChen
VIP Member
4,210
24,567
Nov 2023
San Francisco, CA
May 25, 2026 at 11:13 AM#4

This one has a reasonably settled answer, so here it is. Prices dramatically below market are the strongest single signal, and the reason is arithmetic rather than suspicion. Synthesis, testing, and cold-chain shipping have floors. A price well under the floor means something was skipped, and the two things that get skipped are testing and content.

46 16mike.trainer_LA, sarah_nash92, FitDadDave and 43 others
Reply Quote Save Share Report
MarkLI_maint
Member
534
2,345
Jun 2024
Long Island, NY
May 25, 2026 at 11:43 AM#5
Dr.GutHealth said:
The useful checklist is about verifiability rather than presentation.

Same pattern here, and in the same order. I had assumed I was the exception until I read this.

Last edited: May 25, 2026 at 4:43 PM
45 15bri_stats, pete_manc_UK, anna.melb_AU and 42 others
Reply Quote Save Share Report

Similar Threads

⚠ Peptide Sciences SHUT DOWN March 6, 2026 — what happened and what to do now8 replies
⚠ Amino Asylum raided by FDA June 2025 — warehouse seized6 replies
⚠ Swiss Chems FDA warning letter December 2024 — selling unapproved drugs6 replies
⚠ 50+ FDA warning letters sent to peptide vendors in 2025 — full list4 replies
⚠ PeptideMeter exposed: some vendors scoring E grade on basic peptides4 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register